EE119 Development of a De Novo Model to Assess the Cost-Effectiveness of a New Treatment Option for Patients With Primary Immunoglobulin a Nephropathy (IgAN)
Abstract
Authors
N. Davies O. Dickinson L. Downward D. Pitcher D. Gale P. Ioannou K. Kipentzoglou M. Crabtree